SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001578563-22-000030
Filing Date
2022-10-03
Accepted
2022-10-03 17:09:45
Documents
2
Period of Report
2022-09-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3408
2 POA poanovaquestandnq.txt EX-99 3479
  Complete submission text file 0001578563-22-000030.txt   9113
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4208 SIX FORKS ROAD, SUITE 920 RALEIGH NC 27609
Business Address 4208 SIX FORKS ROAD, SUITE 920 RALEIGH NC 27609 9194598620
NQ POF V GP, Ltd. (Reporting) CIK: 0001949220 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-31918 | Film No.: 221288380

Mailing Address 4208 SIX FORKS ROAD, SUITE 920 RALEIGH NC 27609
Business Address 4208 SIX FORKS ROAD, SUITE 920 RALEIGH NC 27609 9194598620
NovaQuest Co-Investment Fund XV, L.P. (Reporting) CIK: 0001949248 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-31918 | Film No.: 221288381